These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 17310798)

  • 1. [Quality of life and cost-effect aspects of epilepsy pharmacotherapy of women].
    Iutskova EV; Avakian GN; Tatarinova MIu
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(1):52-5. PubMed ID: 17310798
    [No Abstract]   [Full Text] [Related]  

  • 2. [The "cost-benefit" analysis of new antiepileptic drugs].
    Vlasov PN; Orekhova NV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(10 Pt 1):39-43. PubMed ID: 22500311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacoeconomics of anti-epileptic drugs as adjunctive therapy for refractory epilepsy.
    Simoens S
    Expert Rev Pharmacoecon Outcomes Res; 2010 Jun; 10(3):309-15. PubMed ID: 20545595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary care treatment of epilepsy with phenobarbital in rural China: cost-outcome analysis from the WHO/ILAE/IBE global campaign against epilepsy demonstration project.
    Ding D; Hong Z; Chen GS; Dai XY; Wu JZ; Wang WZ; De Boer HM; Sander JW; Prilipko L; Chisholm D
    Epilepsia; 2008 Mar; 49(3):535-9. PubMed ID: 18302628
    [No Abstract]   [Full Text] [Related]  

  • 5. [Some medical-social aspects of the therapy of epilepsy with drugs of new generation: financial side].
    Gromov SA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2001; 101(8):59-61. PubMed ID: 11552639
    [No Abstract]   [Full Text] [Related]  

  • 6. The pharmacoeconomics of the new antiepileptic drugs.
    Heaney D
    Epilepsia; 1999; 40 Suppl 8():25-31. PubMed ID: 10563592
    [No Abstract]   [Full Text] [Related]  

  • 7. Lacosamide as treatment of epileptic seizures - cost utility results for Sweden.
    Bolin K; Berggren F; Forsgren L
    Acta Neurol Scand; 2010 Jun; 121(6):406-12. PubMed ID: 20199516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Investigation of efficacy of convulex-retard in epilepsy treatment].
    Gromov SA; Korovina SA; Eroshina ES
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(5):35-7. PubMed ID: 16768223
    [No Abstract]   [Full Text] [Related]  

  • 9. [The use of topamax in the treatment of epilepsy: clinical and pharmacoeconomic aspects].
    Gekht AB; Mil'chakova LE; Gusev EI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(12):40-4. PubMed ID: 18427458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determining costs and cost-effectiveness of epilepsy.
    van Hout B
    Am J Manag Care; 1998 Sep; 4(9 Suppl):S501-9. PubMed ID: 10185987
    [No Abstract]   [Full Text] [Related]  

  • 11. Quality of life as an outcome measure for epilepsy clinical trials.
    Cramer JA
    Pharm World Sci; 1997 Oct; 19(5):227-30. PubMed ID: 9368923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Problem of managing patients with epilepsy in developing countries.
    Kuruvilla A
    Epilepsia; 1999 Oct; 40(10):1465-6. PubMed ID: 10528947
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparison of surgical and medical costs for refractory epilepsy.
    Platt M; Sperling MR
    Epilepsia; 2002; 43 Suppl 4():25-31. PubMed ID: 12059998
    [No Abstract]   [Full Text] [Related]  

  • 14. Cost-effectiveness of pediatric epilepsy surgery compared to medical treatment in children with intractable epilepsy.
    Widjaja E; Li B; Schinkel CD; Puchalski Ritchie L; Weaver J; Snead OC; Rutka JT; Coyte PC
    Epilepsy Res; 2011 Mar; 94(1-2):61-8. PubMed ID: 21306874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjunctive therapy in epilepsy: a cost-effectiveness comparison of two AEDs.
    Selai CE; Smith K; Trimble MR
    Seizure; 1999 Feb; 8(1):8-13. PubMed ID: 10091841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Epilepsy in adults: a costs-of-illness study].
    Vlasov PK; Orekhova NV; Filatova NV; Leonova MV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(3 Suppl 2):44-7. PubMed ID: 20873473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Side-effects of antiepileptic drugs: the economic burden.
    de Kinderen RJ; Evers SM; Rinkens R; Postulart D; Vader CI; Majoie MH; Aldenkamp AP
    Seizure; 2014 Mar; 23(3):184-90. PubMed ID: 24315662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Convulex and its place in epilepsy treatment with original valproates].
    Gromov SA; Kim KV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2002; 102(9):18-21. PubMed ID: 12378876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cost-effectiveness decision model for antiepileptic drug treatment in newly diagnosed epilepsy patients.
    Knoester PD; Deckers CL; Termeer EH; Boendermaker AJ; Kotsopoulos IA; de Krom MC; Keyser T; Renier WO; Hekster YA; Severens HL
    Value Health; 2007; 10(3):173-82. PubMed ID: 17532810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic burden of epilepsy in a developing country: a retrospective cost analysis in China.
    Hong Z; Qu B; Wu XT; Yang TH; Zhang Q; Zhou D
    Epilepsia; 2009 Oct; 50(10):2192-8. PubMed ID: 19583782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.